QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-of-a-securities-maintains-buy-on-hims--hers-health-lowers-price-target-to-20

B of A Securities analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Buy and lowers the price target...

 novo-nordisk-reports-positive-results-of-weight-loss-drug-liraglutide-for-children-as-young-as-6-eyes-fda-and-ema-approval

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The compan...

 hims--hers-health-inc-files-for-mixed-shelf-offering-size-not-disclosed

- SEC Filing

 battle-over-compounded-weight-loss-medications---sustainability-and-regulation

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

Core News & Articles

- Reuters 

 why-hims--hers-health-stock-is-falling

Eli Lilly's launch of the competitively priced Zepbound has triggered a 4.9% drop in Hims & Hers' stock. This has r...

 hims--hers-health-sees-major-growth-opportunity-in-booming-weight-loss-market-says-analyst

Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive...

 needham-initiates-coverage-on-hims--hers-health-with-buy-rating-announces-price-target-of-24

Needham analyst Ryan MacDonald initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Pric...

 telehealth-firm-hims--hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-shortages

Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss ...

 deutsche-bank-maintains-hold-on-hims--hers-health-raises-price-target-to-23

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from ...

 piper-sandler-reiterates-neutral-on-hims--hers-health-maintains-18-price-target

Piper Sandler analyst Korinne Wolfmeyer reiterates Hims & Hers Health (NYSE:HIMS) with a Neutral and maintains $18 price...

Core News & Articles

NVDAWAYINTCAAPLMADELOTHIMSPLTRQQQTSLAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment  NVDAWAYINTCA...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION